Adrecizumab: an investigational agent for the biomarker-guided treatment of sepsis-Reference-Cited by-同舟云学术

Adrecizumab: an investigational agent for the biomarker-guided treatment of sepsis

Published:2020-12-21 Issue:2 Volume:30 Page:95-102
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Deniau Benjamin¹²³^ORCID,Takagi Koji³,Asakage Ayu³,Mebazaa Alexandre¹²³

Affiliation:

1. Department of Anesthesiology and Critical Care and Burn Unit, Assistance Publique — Hôpitaux De Paris (AP—HP), Groupe Hospitalier St Louis-Lariboisière, Paris, France

2. Université de Paris, FHU PROMICE, Paris, France

3. INSERM UMR-S 942 MASCOT, Lariboisière Hospital, Institut National de la Santé et de la Recherche Médicale, Paris, France

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2021.1857365

Reference43 articles.

1. Benchmarking the Incidence and Mortality of Severe Sepsis in the United States*

2. Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit

3. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

4. Endothelial Responses in Sepsis

5. DAMPs and NETs in Sepsis

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endothelial cell dysfunction and targeted therapeutic drugs in sepsis;Heliyon;2024-07

2. Immunological alterations in the endothelial barrier: a new predictive and therapeutic paradigm for sepsis;Expert Review of Clinical Immunology;2024-06-11

3. Postoperative bioactive adrenomedullin is associated with the onset of ARDS and adverse outcomes in patients undergoing open thoracoabdominal aortic surgery;Scientific Reports;2024-06-04

4. The Mechanisms of Endothelium in Sepsis Induced Coagulation Disorders and Potential Therapy;Advances in Clinical Medicine;2024

5. Prognostic Value for Mortality of Plasma Bioactive Adrenomedullin in Patients with Pulmonary Arterial Hypertension: A Sub Analysis of the Biomarker Study in the COHARD-PH Registry;Medicina;2023-04-12